Immunotherapy in Allergies: An Update

Author(s): Zamir Calamita, Simone Bernardino Potthast

Journal Name: Inflammation & Allergy - Drug Targets (Discontinued)
(Formerly Current Drug Targets - Inflammation & Allergy)

Volume 12 , Issue 1 , 2013


The allergen specific immunotherapy is the administration, in IgE-mediated allergic patients, of a specific allergen in a gradually increased number to provide protection against allergic symptoms and inflammatory reaction. The current immunotherapeutic approaches occur by modulating the release of inflammatory mediators involved in allergic reaction and consequently the inhibition of allergic inflammatory process. Since 1997 several World Associations of Allergy, Asthma and Immunology, have reviewed this issue, seeking to establish standards for its use. Also many publications about the immunotherapy’s efficacy, as well as, several guidelines on the use of immunotherapy in the treatment of allergic are available. This article will focus on the most current evidence about the immunotherapy in allergies regarding its mechanism of action, effectiveness and practical considerations.

Keywords: Allergy, asthma, immunotherapy, inflammation, rhinitis, T cells, review, sublingual immunotherapy, TNF receptor-related-protein, Langerhans cells

promotion: free to download

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2013
Page: [12 - 18]
Pages: 7
DOI: 10.2174/1871528111312010003

Article Metrics

PDF: 27